| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.02 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |